Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 50


Autophagy RIPs into cell death.

Goodall ML, Cramer SD, Thorburn A.

Cell Cycle. 2016 Nov 16;15(22):3014-3015. Epub 2016 Aug 30. No abstract available.


Autophagy complexes cell death by necroptosis.

Goodall ML, Cramer SD, Thorburn A.

Oncotarget. 2016 Aug 9;7(32):50818-50819. doi: 10.18632/oncotarget.10640. No abstract available.


The Autophagy Machinery Controls Cell Death Switching between Apoptosis and Necroptosis.

Goodall ML, Fitzwalter BE, Zahedi S, Wu M, Rodriguez D, Mulcahy-Levy JM, Green DR, Morgan M, Cramer SD, Thorburn A.

Dev Cell. 2016 May 23;37(4):337-349. doi: 10.1016/j.devcel.2016.04.018.


SPOP the mutation.

Rider L, Cramer SD.

Elife. 2015 Oct 27;4. pii: e11760. doi: 10.7554/eLife.11760.


Antenatal endotoxin disrupts lung vitamin D receptor and 25-hydroxyvitamin D 1α-hydroxylase expression in the developing rat.

Mandell E, Seedorf GJ, Ryan S, Gien J, Cramer SD, Abman SH.

Am J Physiol Lung Cell Mol Physiol. 2015 Nov 1;309(9):L1018-26. doi: 10.1152/ajplung.00253.2015. Epub 2015 Sep 4.


Coordinate loss of MAP3K7 and CHD1 promotes aggressive prostate cancer.

Rodrigues LU, Rider L, Nieto C, Romero L, Karimpour-Fard A, Loda M, Lucia MS, Wu M, Shi L, Cimic A, Sirintrapun SJ, Nolley R, Pac C, Chen H, Peehl DM, Xu J, Liu W, Costello JC, Cramer SD.

Cancer Res. 2015 Mar 15;75(6):1021-34. doi: 10.1158/0008-5472.CAN-14-1596.


Changes in Susceptibility to Oncolytic Vesicular Stomatitis Virus during Progression of Prostate Cancer.

Yu N, Puckett S, Antinozzi PA, Cramer SD, Lyles DS.

J Virol. 2015 May;89(10):5250-63. doi: 10.1128/JVI.00257-15. Epub 2015 Mar 4.


Inhibition of Lipid Oxidation Increases Glucose Metabolism and Enhances 2-Deoxy-2-[(18)F]Fluoro-D-Glucose Uptake in Prostate Cancer Mouse Xenografts.

Schlaepfer IR, Glodé LM, Hitz CA, Pac CT, Boyle KE, Maroni P, Deep G, Agarwal R, Lucia SM, Cramer SD, Serkova NJ, Eckel RH.

Mol Imaging Biol. 2015 Aug;17(4):529-38. doi: 10.1007/s11307-014-0814-4.


Lipid catabolism via CPT1 as a therapeutic target for prostate cancer.

Schlaepfer IR, Rider L, Rodrigues LU, Gijón MA, Pac CT, Romero L, Cimic A, Sirintrapun SJ, Glodé LM, Eckel RH, Cramer SD.

Mol Cancer Ther. 2014 Oct;13(10):2361-71. doi: 10.1158/1535-7163.MCT-14-0183. Epub 2014 Aug 13.


Influence of stromal-epithelial interactions on androgen action.

Nieto CM, Rider LC, Cramer SD.

Endocr Relat Cancer. 2014 Aug;21(4):T147-60. doi: 10.1530/ERC-14-0138. Epub 2014 May 28. Review.


Silibinin prevents prostate cancer cell-mediated differentiation of naïve fibroblasts into cancer-associated fibroblast phenotype by targeting TGF β2.

Ting HJ, Deep G, Jain AK, Cimic A, Sirintrapun J, Romero LM, Cramer SD, Agarwal C, Agarwal R.

Mol Carcinog. 2015 Sep;54(9):730-41. doi: 10.1002/mc.22135. Epub 2014 Feb 24.


A role for interleukin-1 alpha in the 1,25 dihydroxyvitamin D3 response in mammary epithelial cells.

Maund SL, Shi L, Cramer SD.

PLoS One. 2013 Nov 7;8(11):e81367. doi: 10.1371/journal.pone.0081367. eCollection 2013.


Genetic markers associated with early cancer-specific mortality following prostatectomy.

Liu W, Xie CC, Thomas CY, Kim ST, Lindberg J, Egevad L, Wang Z, Zhang Z, Sun J, Sun J, Koty PP, Kader AK, Cramer SD, Bova GS, Zheng SL, Grönberg H, Isaacs WB, Xu J.

Cancer. 2013 Jul 1;119(13):2405-12. doi: 10.1002/cncr.27954. Epub 2013 Apr 22.


Suppression of Tak1 promotes prostate tumorigenesis.

Wu M, Shi L, Cimic A, Romero L, Sui G, Lees CJ, Cline JM, Seals DF, Sirintrapun JS, McCoy TP, Liu W, Kim JW, Hawkins GA, Peehl DM, Xu J, Cramer SD.

Cancer Res. 2012 Jun 1;72(11):2833-43. doi: 10.1158/0008-5472.CAN-11-2724. Epub 2012 Mar 30.


Hydroxyproline metabolism in mouse models of primary hyperoxaluria.

Knight J, Holmes RP, Cramer SD, Takayama T, Salido E.

Am J Physiol Renal Physiol. 2012 Mar 15;302(6):F688-93. doi: 10.1152/ajprenal.00473.2011. Epub 2011 Dec 21.


Effect of dietary polyunsaturated fatty acids on castration-resistant Pten-null prostate cancer.

Wang S, Wu J, Suburu J, Gu Z, Cai J, Axanova LS, Cramer SD, Thomas MJ, Perry DL, Edwards IJ, Mucci LA, Sinnott JA, Loda MF, Sui G, Berquin IM, Chen YQ.

Carcinogenesis. 2012 Feb;33(2):404-12. doi: 10.1093/carcin/bgr290. Epub 2011 Dec 8.


Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancer.

Liu W, Lindberg J, Sui G, Luo J, Egevad L, Li T, Xie C, Wan M, Kim ST, Wang Z, Turner AR, Zhang Z, Feng J, Yan Y, Sun J, Bova GS, Ewing CM, Yan G, Gielzak M, Cramer SD, Vessella RL, Zheng SL, Grönberg H, Isaacs WB, Xu J.

Oncogene. 2012 Aug 30;31(35):3939-48. doi: 10.1038/onc.2011.554. Epub 2011 Dec 5.


Isolation of prostate tumor initiating cells (TICs) through their dielectrophoretic signature.

Salmanzadeh A, Romero L, Shafiee H, Gallo-Villanueva RC, Stremler MA, Cramer SD, Davalos RV.

Lab Chip. 2012 Jan 7;12(1):182-9. doi: 10.1039/c1lc20701f. Epub 2011 Nov 9.


Interleukin-1α mediates the antiproliferative effects of 1,25-dihydroxyvitamin D3 in prostate progenitor/stem cells.

Maund SL, Barclay WW, Hover LD, Axanova LS, Sui G, Hipp JD, Fleet JC, Thorburn A, Cramer SD.

Cancer Res. 2011 Aug 1;71(15):5276-86. doi: 10.1158/0008-5472.CAN-10-2160. Epub 2011 Jun 8.


Pancreatic cancer with Nest-in tendencies.

Maund SL, Cramer SD.

Cancer Biol Ther. 2011 Mar 15;11(6):559-61. Epub 2011 Mar 15. No abstract available.

Supplemental Content

Loading ...
Support Center